News
The chief scientist at German/US biotech hybrid Immatics is moving to the helm
EndPoint News | 7/08/2019
MD Anderson Cancer Center and Ascentage Pharma announce strategic alliance in cancer drug development
MD Anderson News | 1/06/2019
Salarius Pharmaceuticals and Flex Pharma Announce Merger Agreement
Salarius Pharmaceuticals | 1/04/2019
MD Anderson and Cyclacel Pharmaceuticals announce strategic alliance to study novel Cyclacel medicines in hematological malignancies
MD Anderson News | 10/04/2018
MD Anderson immunologist Jim Allison awarded Nobel Prize
MD Anderson News | 10/01/2018
MD Anderson immunotherapy expert Sharma wins Coley Award
MD Anderson News | 9/18/2018
PARP inhibitor improves progression-free survival in patients with advanced breast cancers and BRCA mutations
MD Anderson News | 12/08/2017
MD Anderson and Lion Biotechnologies announce strategic alliance to conduct clinical trials of TILs in multiple solid tumors
MD Anderson News | 4/19/2017
Connect to End Cancer launches at South By Southwest 2017 Conference and Festivals
MD Anderson News | 12/29/2016
M.D. Anderson program is ‘third pillar’ for the cancer center’s success
Houston Business Journal | 12/19/2016
When hospitals welcome innovation, patients reap the benefits
TMC News | 11/17/2016
Two Baylor College of Medicine faculty members named to National Academy of Medicine
Baylor College of Medicine | 10/17/2016
MD Anderson immunologist Jim Allison wins Lasker-DeBakey Award
MD Anderson News | 9/08/2015
New to Houston biotech on the lookout for Headquarters
Houston Business Journal | 4/03/2016
Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push
Xconomy | 3/30/2016
Esperance Pharmaceuticals Names Brett Giroir MD to Board of Directors
PRNewswire | 3/17/2016
JLabs at TMC Opens Houston Campus, Home to 21 Biotech Startups
Xconomy | 3/02/2016
MD Anderson receives $22.2 million in CPRIT research funding
MD Anderson News | 11/20/2015
Esperance Announces Strategic Alliance with MD Anderson Cancer Center
PR Newswire | 8/24/2015